Nanostructured Lipid Carriers Loaded with Dexamethasone Prevent Inflammatory Responses in Primary Non-Parenchymal Liver Cells

• Main Authors: Carolina Medina-Montano (Author), Ignacio Rivero Berti (Author), Rocío C. Gambaro (Author), María José Limeres (Author), Malin Svensson (Author), Gisel Padula (Author), Cecilia Y. Chain (Author), José Sebastián Cisneros (Author), Guillermo R. Castro (Author), Stephan Grabbe (Author), Matthias Bros (Author), Stephan Gehring (Author), German A. Islan (Author), Maximiliano L. Cacicedo (Author)
• Format: Book
• Published: MDPI AG, 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Liver inflammation represents a major clinical problem in a wide range of pathologies. Among the strategies to prevent liver failure, dexamethasone (DXM) has been widely used to suppress inflammatory responses. The use of nanocarriers for encapsulation and sustained release of glucocorticoids to liv...